☆ 4.6 Article

P365 Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Journal of Crohns & Colitis (2017)

Journal

Journal of Crohns & Colitis

Volume 11, Issue suppl_1, Pages S263-S264

Publisher

Oxford University Press (OUP)

DOI: 10.1093/ecco-jcc/jjx002.490

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.